Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 50: 552-558, 2004. First published January 6, 2004; 10.1373/clinchem.2003.027763
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2003.027763v1
50/3/552    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (44)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Herget-Rosenthal, S.
Right arrow Articles by Kribben, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herget-Rosenthal, S.
Right arrow Articles by Kribben, A.
Related Collections
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2004;50:552-558.)
© 2004 American Association for Clinical Chemistry, Inc.

Proteomics and Protein Markers

Prognostic Value of Tubular Proteinuria and Enzymuria in Nonoliguric Acute Tubular Necrosis

Stefan Herget-Rosenthal1,a, Dennis Poppen1, Johannes Hüsing2, Günter Marggraf3, Frank Pietruck1, Heinz-Günther Jakob3, Thomas Philipp1 and Andreas Kribben1

Departments of1 Nephrology and 3 Thoracic and Cardiovascular Surgery, University Hospital, Essen, Germany. 2 Institute for Medical Informatics, Biometry and Epidemiology, Medical School, University of Essen, Essen, Germany.

aAddress correspondence to this author at: Klinik für Nieren - und Hochdruckkrankheiten, Universitätsklinikum Essen, D-45122 Essen, Germany. Fax 49-201-723-5633; e-mail stefan.herget-rosenthal{at}uni-essen.de.

Background: Acute tubular necrosis (ATN) has high mortality, especially in patients who require renal replacement therapy (RRT). We prospectively studied the diagnostic accuracy of the urinary excretion of low-molecular-weight proteins and enzymes as predictors of a need for RRT in ATN.

Methods: In 73 consecutive patients with initially nonoliguric ATN, we measured urinary excretion of {alpha}1- and ß2-microglobulin, cystatin C, retinol-binding protein, {alpha}-glutathione S-transferase, {gamma}-glutamyltransferase, lactate dehydrogenase, and N-acetyl-ß-D-glucosaminidase early in the course of ATN.

Results: Twenty-six patients (36%) required RRT a median of 4 (interquartile range, 2–6) days after detection of proteinuria and enzymuria. Patients who required RRT had higher urinary cystatin C and {alpha}1-microglobulin [median (interquartile range), 1.7 (1.2–4.1) and 34.5 (26.6–45.1) g/mol of creatinine] than patients who did not require RRT [0.1 (0.02–0.5) and 8.0 (5.0–17.5) g/mol of creatinine]. Urinary excretion of cystatin C and {alpha}1-microglobulin had the highest diagnostic accuracies in identifying patients requiring RRT as indicated by the largest areas under the ROC curves: 0.92 (95% confidence interval, 0.86–0.96) and 0.86 (0.78–0.92), respectively. Sensitivity and specificity were 92% (95% confidence interval, 83–96%) and 83% (73–90%), respectively, for urinary cystatin C >1 g/mol of creatinine, and 88% (78–93%) and 81% (70–88%) for urinary {alpha}1-microglobulin >20 g/mol of creatinine.

Conclusion: In nonoliguric ATN, increased urinary excretion of cystatin C and {alpha}1-microglobulin may predict an unfavorable outcome, as reflected by the requirement for RRT.




The following articles in journals at HighWire Press have cited this article:


Home page
 ANN INTERN MEDHome page
T. L. Nickolas, M. J. O'Rourke, J. Yang, M. E. Sise, P. A. Canetta, N. Barasch, C. Buchen, F. Khan, K. Mori, J. Giglio, et al.
Sensitivity and Specificity of a Single Emergency Department Measurement of Urinary Neutrophil Gelatinase-Associated Lipocalin for Diagnosing Acute Kidney Injury
Ann Intern Med, June 3, 2008; 148(11): 810 - 819.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
S. S. Waikar, K. D. Liu, and G. M. Chertow
Diagnosis, Epidemiology and Outcomes of Acute Kidney Injury
Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 844 - 861.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
B. Mahesh, B. Yim, D. Robson, R. Pillai, C. Ratnatunga, and D. Pigott
Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial
Eur. J. Cardiothorac. Surg., March 1, 2008; 33(3): 370 - 376.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
S. G. Coca and C. R. Parikh
Urinary Biomarkers for Acute Kidney Injury: Perspectives on Translation
Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 481 - 490.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
O. Liangos, M. C. Perianayagam, V. S. Vaidya, W. K. Han, R. Wald, H. Tighiouart, R. W. MacKinnon, L. Li, V. S. Balakrishnan, B. J.G. Pereira, et al.
Urinary N-Acetyl-beta-(D)-Glucosaminidase Activity and Kidney Injury Molecule-1 Level Are Associated with Adverse Outcomes in Acute Renal Failure
J. Am. Soc. Nephrol., March 1, 2007; 18(3): 904 - 912.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
R. K. Singal, L. M. Docking, L. G. Girling, M. R. Graham, P. W. Nickerson, B. M. McManus, A. B. Magil, E. K.-Y. Walker, R. K. Warrian, M. S. Cheang, et al.
Biologically variable bypass reduces enzymuria after deep hypothermic circulatory arrest.
Ann. Thorac. Surg., October 1, 2006; 82(4): 1480 - 1488.
[Abstract] [Full Text] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
J. Westhuyzen
Cystatin C: a Promising Marker and Predictor of Impaired Renal Function
Ann. Clin. Lab. Sci., January 1, 2006; 36(4): 387 - 394.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. Conti, M. Zater, K. Lallali, A. Durrbach, S. Moutereau, P. Manivet, P. Eschwege, and S. Loric
Absence of Circadian Variations in Urine Cystatin C Allows Its Use on Urinary Samples
Clin. Chem., January 1, 2005; 51(1): 272 - 273.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
U. Poge, T. Gerhardt, A. Bokenkamp, B. Stoffel-Wagner, H.-U. Klehr, T. Sauerbruch, and R. P. Woitas
Time course of low molecular weight proteins in the early kidney transplantation period--influence of corticosteroids
Nephrol. Dial. Transplant., November 1, 2004; 19(11): 2858 - 2863.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. Gai, V. Cantaluppi, C. Fenocchio, D. Motta, S. Masini, A. Pacitti, and G. Lanfranco
Presence of Protein Fragments in Urine of Critically Ill Patients with Acute Renal Failure: A Nephrologic Enigma
Clin. Chem., October 1, 2004; 50(10): 1822 - 1824.
[Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
S. M. Hewitt, J. Dear, and R. A. Star
Discovery of Protein Biomarkers for Renal Diseases
J. Am. Soc. Nephrol., July 1, 2004; 15(7): 1677 - 1689.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.